Literature DB >> 25667797

Pityriasis rosea in chronic hepatitis C.

Viroj Wiwanitkit1.   

Abstract

Entities:  

Year:  2014        PMID： 25667797      PMCID： PMC4318413          DOI： 10.5152/balkanmedj.2014.14778

Source DB:  PubMed          Journal:  Balkan Med J        ISSN： 2146-3123            Impact factor:   2.021


× No keyword cloud information.
  6 in total

1.  Recurrence of hepatitis C virus infection during pityriasis rosea.

Authors:  Francesco Drago; Sanja Javor; Aurora Parodi
Journal:  Acta Derm Venereol       Date:  2013-07-06       Impact factor: 4.437

2.  Additional evidence that pityriasis rosea is associated with reactivation of human herpesvirus-6 and -7.

Authors:  Francesco Broccolo; Francesco Drago; Anna M Careddu; Chiara Foglieni; Laura Turbino; Clementina E Cocuzza; Carlo Gelmetti; Paolo Lusso; Alfredo E Rebora; Mauro S Malnati
Journal:  J Invest Dermatol       Date:  2005-06       Impact factor: 8.551

3.  Impact of human herpesvirus-6 on the frequency and severity of recurrent hepatitis C virus hepatitis in liver transplant recipients.

Authors:  Nina Singh; Shahid Husain; Donald R Carrigan; Konstance K Knox; Karen E Weck; Marilyn M Wagener; Timothy Gayowski
Journal:  Clin Transplant       Date:  2002-04       Impact factor: 2.863

Review 4.  Pityriasis rosea: an update with a critical appraisal of its possible herpesviral etiology.

Authors:  Francesco Drago; Francesco Broccolo; Alfredo Rebora
Journal:  J Am Acad Dermatol       Date:  2009-08       Impact factor: 11.527

5.  Pityriasis rosea associated with pegylated interferon alfa and ribavirin treatment in a patient with chronic hepatitis C.

Authors:  Rahmet Güner; Siran Keske; Imran Hasanoğlu; Mehmet Taşyaran
Journal:  Balkan Med J       Date:  2013-06-01       Impact factor: 2.021

6.  The role of human herpesvirus 6, human herpesvirus 7, Epstein-Barr virus and cytomegalovirus in the aetiology of pityriasis rosea.

Authors:  B Canpolat Kirac; E Adisen; G Bozdayi; A Yucel; I Fidan; N Aksakal; M A Gurer
Journal:  J Eur Acad Dermatol Venereol       Date:  2008-08-18       Impact factor: 6.166
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.